Latest Off-label use Stories

2011-05-11 06:00:00

BAYSIDE, N.Y. and GERMANTOWN, Md., May 11, 2011 /PRNewswire-USNewswire/ -- The national Tourette Syndrome Association (TSA) and Psyadon Pharmaceuticals Inc.

2011-04-21 07:52:13

Physicians may be misusing and overusing an expensive blood clotting drug, and the practice could be dangerous for patients.

2011-04-06 11:20:36

Despite Federal Drug Administration regulation of the approval and use of pharmaceutical products, "off-label" marketing of drugs (for purposes other than those for which the drug was approved) has occurred in all aspects of the US health care system.

2011-03-06 00:02:31

DoctorDirectory, a leading market services company serving healthcare professionals and pharmaceutical industry clients, surveyed practicing physicians in the US to assess physician attitudes on the FDA's Bad Ad Program. Asheville, NC (Vocus/PRWEB) March 04, 2011 In May, 2010 The US Food and Drug Administration launched a program designed to educate healthcare providers (HCPs) and enlist them in helping the agency spot misleading prescription drug information.

2011-01-13 18:23:27

Drugs that pharmaceutical companies market most aggressively to physicians and patients tend to offer less benefit and more harm to most patients — a phenomenon described as the "inverse benefit law" in a paper from the University of Texas Medical Branch at Galveston.

2011-01-11 09:47:14

A new editorial article, published in the Canadian Medical Association Journal, suggests physicians should be more careful when prescribing drugs "off-label".

2011-01-10 08:54:23

Top-selling drugs, known as atypical antipsychotic medications, lack evidence that they’ll actually be beneficial, according to a new study.

2010-11-19 10:51:00

MUNICH, November 19, 2010 /PRNewswire/ -- Many of the medications used to treat children have been developed almost exclusively for adults and approved for them.

2010-10-20 06:20:00

More than 17,000 healthcare providers, including doctors, have received money from several major drug companies to talk to other doctors about their products.

2010-10-01 14:27:04

Researchers from Boston University School of Medicine (BUSM) and the VA Boston Healthcare System have conducted a study that failed to show a difference in efficacy between Bevacizumab (Avastin) and Ranibizumab (Lucentis) for the treatment of age-related macular degeneration (AMD).

Word of the Day
  • A handkerchief.
  • Specifically— The legendary sweat-cloth; the handkerchief of St. Veronica, according to tradition miraculously impressed with the mask of Christ; also, the napkin about Christ's head (Johu xx. 7).
  • In general, any miraculous portrait of Christ.
The word 'sudarium' comes from a Latin word meaning 'a handkerchief'.